1. A complex life cycle in a warming planet: gene expression in thermally stressed sponges. Issue 7 (4th February 2013) Authors: Webster, N.; Pantile, R.; Botté, E.; Abdo, D.; Andreakis, N.; Whalan, S. Journal: Molecular ecology Issue: Volume 22:Issue 7(2013) Page Start: 1854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Nonlethal Genetic Assay for Discriminating Sex in Brook Trout. (29th April 2021) Authors: Webster, N.; Price, S.; Gowan, C.; Coster, S. S. Journal: North American journal of fisheries management Issue: Volume 41:Number 4(2021) Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of 6-hydroxymelatonin in human macrophage model of inflammasome activation in conditions mimicking sepsis. (February 2021) Authors: Musatti, E.; Webster, N.; Wilson, H.; Galley, H. Journal: British journal of anaesthesia Issue: Volume 126:Number 2(2021) Page Start: e79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. INHIBITION OF N6-METHYLADENOSINE (m6A) MODIFICATION AS A NOVEL TREATMENT STRATEGY FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL). (October 2022) Authors: Mun, L.; Miano, V.; Webster, N.; Andrews, B.; Han, N.; Burke, A.; Barberi, I.; Turner, S. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P673: DEPLETION AND RECOVERY OF NORMAL B-CELLS DURING AND AFTER TREATMENT WITH CHEMOIMMUNOTHERAPY, IBRUTINIB OR VENETOCLAX. (23rd June 2022) Authors: Rawstron, A.; Webster, N.; Pitchford, A.; Dalal, S.; Bloor, A.; de Tute, R.; Hockaday, A.; Jackson, S.; Cairns, D.; Greatorex, N.; Allsup, D.; Munir, T.; Hillmen, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE III NCRI FLAIR TRIAL. (23rd June 2022) Authors: Hillmen, P.; Pitchford, A.; Bloor, A.; Pettitt, A.; Patten, P.; Forconi, F.; Schuh, A.; Fox, C.; Elmusharaf, N.; Gatto, S.; Kennedy, B.; Gribben, J.; Pemberton, N.; Sheehy, O.; Preston, G.; Howard, D.; Hockaday, A.; Cairns, D.; Jackson, S.; Greatorex, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗